SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as it hits multi-year lows amidst intense market skepticism, with community debate sharply divided between those calling for a turnaround based on its dividend yield and those aggressively shorting the stock over leadership, brand relevance, and perceived 'woke' marketing strategies. Investors are closely watching critical support levels as the company struggles to maintain its competitive position against rivals in the athletic footwear sector.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares are facing intensified selling pressure as investors weigh broader retail sector weakness and bearish sentiment spilling over from recent competitors' earnings reports. The community remains deeply divided, with some debating the stock's value as a long-term turnaround play while others express frustration over brand direction, recent executive departures, and lingering concerns about the incoming leadership.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amidst intense community debate over the company's financial performance and the political controversies surrounding its namesake, with users aggressively trading arguments regarding recent military posturing and executive leadership. Investors remain divided between bullish sentiment on potential future mergers and deep skepticism fueled by ongoing litigation and broader market instability.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is facing significant volatility as investors remain divided over the company's aggressive growth strategy versus ongoing concerns about share dilution and the lack of a confirmed earnings date. While some community members are highlighting a potential short squeeze setup driven by heavy short interest and strong revenue expectations, critics continue to demand greater transparency regarding financial filings and leadership accountability.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is gaining significant market attention following a massive five-year, 55 MW hosting agreement with Axe Compute valued at over $500 million, which is driving community speculation about a major re-rate for the company's edge AI infrastructure model. Investors are actively debating the company's growth trajectory and revenue projections for 2026, while short-term volatility persists due to ongoing discussions regarding capital expenditure requirements and potential future share dilution.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis is in the spotlight following the announcement of a massive $70 billion turnaround plan, dubbed "FaSTLAne 2030," which aims to revitalize core brands and reach positive cash flow by 2028. Community sentiment is deeply divided, with some investors viewing the stock as a deeply undervalued cyclical play, while others remain skeptical due to ongoing recall pressures and aggressive restructuring costs.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is trending as investors weigh potential earnings volatility and consumer spending concerns ahead of its quarterly report, with the community actively debating whether current stock levels present a value opportunity or signal further downside. Discussions are centered on the broader impact of interest rates and housing market trends on the firm's Pro and DIY segments.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is surging following positive Phase 2 clinical trial results for its non-hormonal menopause treatment, ABCL635, which met primary endpoints with high efficacy. The community is actively discussing the stock's potential for a massive short squeeze and long-term valuation growth, while debating the impact of a recent capital raise and the company's transition from a discovery platform to a clinical-stage drug developer.

Harvest Portfolios Group Inc - Harvest Diversified High Income Shares ETF (Class A Units)

Investors are closely monitoring Harvest Diversified High Income Shares ETF (HHIS.TSX) due to its broad exposure to trending U.S. equities and its active covered call strategy designed for consistent monthly income. Community discussions frequently center on the fund's modest leverage and its role as a tax-efficient tool for those looking to build a compounding income portfolio within Canadian registered accounts.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors focus on upcoming clinical milestones, including a planned BLA submission for its prostate cancer therapy and data updates for its oncology pipeline, while community discussions highlight a tight float and strong institutional ownership despite recent market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GEHC or LMAT: Which Is the Better Value Stock Right Now?

GEHC vs. LMAT: Which Stock Is the Better Value Option?

LeMaitre Vascular (LMAT) Hit by Profit Taking

LeMaitre Vascular (LMAT) Hit by Profit Taking...

LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Lag Estimates

LeMaitre (LMAT) delivered earnings and revenue surprises of -8.64% and -1.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Estimates

Boston Scientific (BSX) delivered earnings and revenue surprises of +3.61% and +1.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Casey's & 3 More Stocks With Strong Interest Coverage to Buy Now

CASY, CLS, PNTG and LMAT stand out for strong interest coverage as borrowing costs rise, with solid sales/EPS growth estimates and big one-year gains. 

LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why 

LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.

Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround 

LeMaitre (LMAT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

LeMaitre Vascular Enters Oversold Territory

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important...

3 Reasons Growth Investors Will Love LeMaitre (LMAT)

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

LeMaitre (LMAT) Upgraded to Buy: Here's Why

LeMaitre (LMAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Lemaitre Vascular Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

LMATLemaitre Vascular Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest LMAT News